209 related articles for article (PubMed ID: 18784260)
21. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family.
Yuan T; Pang Q; Xing X; Wang X; Li Y; Li J; Wu X; Li M; Wang O; Jiang Y; Dong J; Xia W
Calcif Tissue Int; 2015 Apr; 96(4):265-73. PubMed ID: 25555744
[TBL] [Abstract][Full Text] [Related]
22. Urinary Acidification Does Not Explain the Absence of Nephrocalcinosis in a Mouse Model of Familial Hypomagnesaemia with Hypercalciuria and Nephrocalcinosis (FHHNC).
Al-Shebel A; Michel G; Breiderhoff T; Müller D
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339056
[TBL] [Abstract][Full Text] [Related]
23. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene.
Hampson G; Konrad MA; Scoble J
BMC Nephrol; 2008 Sep; 9():12. PubMed ID: 18816383
[TBL] [Abstract][Full Text] [Related]
24. Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium.
Hou J; Shan Q; Wang T; Gomes AS; Yan Q; Paul DL; Bleich M; Goodenough DA
J Biol Chem; 2007 Jun; 282(23):17114-22. PubMed ID: 17442678
[TBL] [Abstract][Full Text] [Related]
25. Hydrochlorothiazide in CLDN16 mutation.
Zimmermann B; Plank C; Konrad M; Stöhr W; Gravou-Apostolatou C; Rascher W; Dötsch J
Nephrol Dial Transplant; 2006 Aug; 21(8):2127-32. PubMed ID: 16595585
[TBL] [Abstract][Full Text] [Related]
26. Hypomagnesemia-hypercalciuria-nephrocalcinosis and ocular findings: a new claudin-19 mutation.
Ekinci Z; Karabaş L; Konrad M
Turk J Pediatr; 2012; 54(2):168-70. PubMed ID: 22734304
[TBL] [Abstract][Full Text] [Related]
27. Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations.
Sikora P; Zaniew M; Haisch L; Pulcer B; Szczepańska M; Moczulska A; Rogowska-Kalisz A; Bieniaś B; Tkaczyk M; Ostalska-Nowicka D; Zachwieja K; Hyla-Klekot L; Schlingmann KP; Konrad M
Nephrol Dial Transplant; 2015 Apr; 30(4):636-44. PubMed ID: 25477417
[TBL] [Abstract][Full Text] [Related]
28. Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1).
Knohl SJ; Scheinman SJ
Semin Nephrol; 2004 Jan; 24(1):55-60. PubMed ID: 14730510
[TBL] [Abstract][Full Text] [Related]
29. Claudins and nephrolithiasis.
Plain A; Alexander RT
Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):268-276. PubMed ID: 29782346
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation of the claudin 16 gene in familial hypomagnesemia with hypercalciuria and nephrocalcinosis mimicking rickets.
Kasapkara CS; Tumer L; Okur I; Hasanoglu A
Genet Couns; 2011; 22(2):187-92. PubMed ID: 21848011
[TBL] [Abstract][Full Text] [Related]
31. Hypomagnesemia with hypercalciuria and nephrocalcinosis: case report and a family study.
Tasic V; Dervisov D; Koceva S; Weber S; Konrad M
Pediatr Nephrol; 2005 Jul; 20(7):1003-6. PubMed ID: 15856319
[TBL] [Abstract][Full Text] [Related]
32. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface expression of a novel Claudin-16 mutant that lacks the entire C-terminal cytosolic tail.
Müller D; Kausalya PJ; Meij IC; Hunziker W
Hum Mol Genet; 2006 Apr; 15(7):1049-58. PubMed ID: 16501001
[TBL] [Abstract][Full Text] [Related]
33. Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis Due to CLDN16 Gene Mutations: Novel Findings in Two Cases with Diverse Clinical Features.
Eltan M; Yavas Abali Z; Turkyilmaz A; Gokce I; Abali S; Alavanda C; Arman A; Kirkgoz T; Guran T; Hatun S; Bereket A; Turan S
Calcif Tissue Int; 2022 Apr; 110(4):441-450. PubMed ID: 34761296
[TBL] [Abstract][Full Text] [Related]
34. Hypomagnesemia and nephrocalcinosis in a patient with two heterozygous mutations in the CLDN16 gene.
Staiger K; Staiger H; Haas C; Thamer C; Risler T; Machicao F; Häring HU
J Nephrol; 2007; 20(1):107-10. PubMed ID: 17347984
[TBL] [Abstract][Full Text] [Related]
35. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease.
Naeem M; Hussain S; Akhtar N
Am J Nephrol; 2011; 34(3):241-8. PubMed ID: 21791920
[TBL] [Abstract][Full Text] [Related]
36. Claudin-16 and claudin-19 function in the thick ascending limb.
Hou J; Goodenough DA
Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):483-8. PubMed ID: 20616717
[TBL] [Abstract][Full Text] [Related]
37. Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC.
Tajima T; Nakae J; Fujieda K
Pediatr Nephrol; 2003 Dec; 18(12):1280-2. PubMed ID: 14586675
[TBL] [Abstract][Full Text] [Related]
38. Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene.
Radonsky V; Kizys MML; Dotto RP; Esper PLG; Heilberg IP; Dias-da-Silva MR; Lazaretti-Castro M
Calcif Tissue Int; 2020 Oct; 107(4):403-408. PubMed ID: 32710267
[TBL] [Abstract][Full Text] [Related]
39. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: the first four patients in Serbia.
Peco-Antić A; Konrad M; Milosevski-Lomić G; Dimitrijević N
Srp Arh Celok Lek; 2010; 138(5-6):351-5. PubMed ID: 20607983
[TBL] [Abstract][Full Text] [Related]
40. Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations.
Perdomo-Ramirez A; de Armas-Ortiz M; Ramos-Trujillo E; Suarez-Artiles L; Claverie-Martin F
BMC Med Genet; 2019 Jan; 20(1):6. PubMed ID: 30621608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
